Akari Therapeutics (AKTX) EPS (Basic) Growth (1y) (2015 - 2026)
Akari Therapeutics (AKTX) EPS (Basic) Growth (1y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | -51.11% |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | 186.69% |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | 104.24% |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | -79.34% |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | -52.19% |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | -100.01% |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | 61.11% |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | - |
| 10 | Regeneron Pharmaceuticals | 63.59 Bn | 54.83 Bn | 3.31 Bn | -7.78% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -79.34% |
| Dec 31, 2025 | -2,000,817.32% |
| Sep 30, 2025 | 31.43% |
| Jun 30, 2025 | 89.16% |
| Mar 31, 2025 | 84.75% |
| Dec 31, 2024 | 69.59% |
| Sep 30, 2024 | 37.81% |
| Jun 30, 2024 | 11.01% |
| Mar 31, 2024 | 27.12% |
| Dec 31, 2020 | -134.01% |
| Sep 30, 2020 | 95.50% |
| Jun 30, 2020 | 43.39% |
| Mar 31, 2020 | -23,460.13% |
| Mar 31, 2016 | -50.00% |
| Dec 31, 2015 | 300.00% |
| Sep 30, 2015 | -1,862.13% |
| Jun 30, 2015 | 25.00% |
| Mar 31, 2015 | 95.00% |